BNOX Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Bionomics Ltd

Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation

a year ago - By: Bionomics Ltd

Results of Scheme Meeting

a year ago - By: Bionomics Ltd

Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting

a year ago - By: Bionomics Ltd

Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States

a year ago - By: Benzinga - Mentions: LIFW BTCT API XBP ...

Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

a year ago - By: Benzinga - Mentions: MQ VRCA BVS ALBT ...

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September

a year ago - By: Bionomics Ltd

Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement

a year ago - By: Bionomics Ltd

Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program

a year ago - By: Bionomics Ltd

Bionomics to Present at the ThinkEquity Conference

a year ago - By: Bionomics Ltd

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

a year ago - By: Bionomics Ltd

Bionomics Limited announces intention to re-domicile to the United States

a year ago - By: Bionomics Ltd

Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

a year ago - By: InvestorPlace - Mentions: BURU CDT DGLY EAT ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

a year ago - By: InvestorPlace - Mentions: PMEC NUZE PITA POWL ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

a year ago - By: Bionomics Ltd

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

a year ago - By: Bionomics Ltd

Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024

a year ago - By: InvestorPlace - Mentions: SERV SXTP HE PW ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

a year ago - By: InvestorPlace - Mentions: CHUY ONCO APLM DSY ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

a year ago - By: Bionomics Ltd

BIONOMICS LTD-ADR (BNOX) Stock News

BNOX Latest News, Press Relases and Analysis

Bionomics Announces Supreme Court of New South Wales Approves Bionomics’ Re-Domiciliation

Results of Scheme Meeting

Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting

Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States

Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September

Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement

Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program

Bionomics to Present at the ThinkEquity Conference

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

Bionomics Limited announces intention to re-domicile to the United States

Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder